Ombudsman "not satisfied" with EMA's explanation of disclosure policy changes

Save

The battle of wits between the European Medicines Agency and the European Ombudsman over the EMA's clinical trial data disclosure policy has been ratcheted up a couple of notches after the Ombudsman, Emily O'Reilly, rejected the agency's arguments in…